Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-Course Radiotherapy in Locally Advanced Rectal Cancer.
Cambray M, Gonzalez-Viguera J, Berenguer MA, Macià M, Losa F, Soler G, Frago R, Castellví J, Guinó E. Cambray M, et al. Clin Transl Gastroenterol. 2020 Jun;11(6):e00162. doi: 10.14309/ctg.0000000000000162. Clin Transl Gastroenterol. 2020. PMID: 32568477 Free PMC article.
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.
García M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F, Pisa A, Cambray M, Soler G, Lema L, Kreisler E, Figueras A, Juan XS, Viñals F, Biondo S, Salazar R. García M, et al. Among authors: cambray m. BMC Cancer. 2015 Feb 26;15:59. doi: 10.1186/s12885-015-1052-0. BMC Cancer. 2015. PMID: 25886275 Free PMC article. Clinical Trial.
Sex differences in hospital readmission among colorectal cancer patients.
González JR, Fernandez E, Moreno V, Ribes J, Peris M, Navarro M, Cambray M, Borràs JM. González JR, et al. Among authors: cambray m. J Epidemiol Community Health. 2005 Jun;59(6):506-11. doi: 10.1136/jech.2004.028902. J Epidemiol Community Health. 2005. PMID: 15911648 Free PMC article.
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
Maurel J, Sánchez-Cabús S, Laquente B, Gaba L, Visa L, Fabregat J, Povés I, Roselló S, Díaz-Beveridge R, Martín-Richard M, Rodriguez J, Sabater L, Conill C, Cambray M, Reig A, Ayuso JR, Valls C, Ferrández A, Bombí JA, Ginés A, García-Albéniz X, Fernández-Cruz L. Maurel J, et al. Among authors: cambray m. Cancer Chemother Pharmacol. 2018 Dec;82(6):935-943. doi: 10.1007/s00280-018-3682-9. Epub 2018 Sep 17. Cancer Chemother Pharmacol. 2018. PMID: 30225601 Clinical Trial.
Diet and K-ras mutations in colorectal cancer.
Moreno V, Guinó E, Bosch FX, Peinado M, Capellà G, Navarro M, Martí J, Cambray M, Lloberas B; Bellvitge Colorectal Cancer Study Group. Moreno V, et al. Among authors: cambray m. IARC Sci Publ. 2002;156:501-2. IARC Sci Publ. 2002. PMID: 12484243 No abstract available.
22 results